{{chembox
| verifiedrevid = 444438851
| ImageFile= Mivazerol.png
| ImageSize=200px
| IUPACName=2-Hydroxy-3-(3''H''-imidazol-4-ylmethyl)benzamide
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W5P1SSA8KD
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54780
| InChI = 1/C11H11N3O2/c12-11(16)9-3-1-2-7(10(9)15)4-8-5-13-6-14-8/h1-3,5-6,15H,4H2,(H2,12,16)(H,13,14)
| InChIKey = RLHGFJMGWQXPBW-UHFFFAOYAF
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H11N3O2/c12-11(16)9-3-1-2-7(10(9)15)4-8-5-13-6-14-8/h1-3,5-6,15H,4H2,(H2,12,16)(H,13,14)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RLHGFJMGWQXPBW-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=125472-02-8
| PubChem=60784
| SMILES = O=C(c1c(O)c(ccc1)Cc2cncn2)N
| MeSHName=Mivazerol
  }}
|Section2={{Chembox Properties
| Formula=C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>
| MolarMass=217.22 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Mivazerol''' is an [[alpha-adrenergic agonist]].<ref name="pmid10455094">{{cite journal |vauthors=Fox K, Dargie HJ, de Bono DP, Oliver MF, Wülfert E, Kharkevitch T |title=Effect of an alpha(2) agonist (mivazerol) on limiting myocardial ischaemia in stable angina |journal=Heart |volume=82 |issue=3 |pages=383–5 |date=September 1999 |pmid=10455094 |pmc=1729187 |doi= 10.1136/hrt.82.3.383 |url=http://heart.bmj.com/cgi/pmidlookup?view=long&pmid=10455094}}</ref>

==References==
{{reflist}}

{{Adrenergic agonists}}

[[Category:Imidazoles]]
[[Category:Alpha-adrenergic agonists]]
[[Category:Salicylamides]]


{{organic-compound-stub}}